Author:
Abraham Ambily,Natraj Usha,Karande Anjali A.,Gulati Ashutosh,Murthy Mathur R. N.,Murugesan Sathyabalan,Mukunda Pavithra,Savithri Handanahal S.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Scott, A. M., Wolchok, J. D. & Old, L. J. Antibody therapy of cancer. Nat. Rev. Cancer 12, 278–287 (2012).
2. Chames, P., Van Regenmortel, M., Weiss, E. & Baty, D. Therapeutic antibodies: successes, limitations and hopes for the future. Br. J. Pharmacol. 157, 220–233 (2009).
3. Albanell, J. & Baselga, J. Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer. Drugs Today (Barc). 35, 931–946 (1999).
4. Albanell, J., Codony, J., Rovira, A., Mellado, B. & Gascon, P. Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv. Exp. Med. Biol. 532, 253–268 (2003).
5. Weidle, U. H., Maisel, D., Brinkmann, U. & Tiefenthaler, G. The translational potential for target validation and therapy using intracellular antibodies in oncology. Cancer Genom.Proteom 10, 239–250 (2013).
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献